Deutsche Bank AG Has $49.11 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Deutsche Bank AG raised its stake in DocuSign, Inc. (NASDAQ:DOCU) by 26.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 546,078 shares of the company’s stock after buying an additional 113,608 shares during the period. Deutsche Bank AG owned 0.27% of DocuSign worth $49,114,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in DOCU. Rhumbline Advisers increased its stake in shares of DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after buying an additional 330,136 shares during the period. KBC Group NV increased its stake in shares of DocuSign by 32.7% in the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after buying an additional 378,233 shares during the period. Jennison Associates LLC acquired a new position in shares of DocuSign in the fourth quarter valued at approximately $12,897,000. Principal Financial Group Inc. lifted its holdings in DocuSign by 3,026.7% during the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock worth $49,179,000 after buying an additional 529,308 shares during the period. Finally, Amundi lifted its holdings in DocuSign by 565.8% during the 4th quarter. Amundi now owns 1,379,575 shares of the company’s stock worth $123,486,000 after buying an additional 1,172,368 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Stock Performance

Shares of DOCU opened at $90.34 on Wednesday. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The business’s 50 day moving average price is $80.47 and its two-hundred day moving average price is $84.75. The firm has a market cap of $18.29 billion, a PE ratio of 18.63, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU) last issued its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period last year, the business posted $0.76 EPS. Research analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at $6,765,251.90. This trade represents a 9.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 55,851 shares of company stock worth $4,607,439 in the last three months. Company insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on DOCU shares. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Thursday, April 17th. Citigroup lifted their target price on DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 14th. Jefferies Financial Group cut their target price on DocuSign from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, March 31st. UBS Group decreased their price objective on shares of DocuSign from $90.00 to $85.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Finally, Wedbush reiterated a “neutral” rating and set a $100.00 price objective on shares of DocuSign in a research report on Friday, March 14th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $92.46.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.